Astrazeneca Share News (AZN)
AZN Share
AZN Share
AZN Share
AZN Share
AZN
AZN Share
AZN Level 2
AZN Live
AZN Broker
AZN Directors
AZN Financial
AZN
AZN Short
AZN
Last checked at -
(Adds details)By Michael NienaberBERLIN, Feb 9 (Reuters) - Germany is planning to spend nearly 9 billion euros ($10.9 billion) this year to buy up to 635.1 million COVID-19 vaccines as part of the European Union's procurement scheme and national d...
Read moreNEW DELHI, Feb 9 (Reuters) - Johnson & Johnson is interested in manufacturing its COVID-19 vaccine in India, a government official told a news conference on Tuesday.India also currently has no concern over the efficacy of the AstraZeneca vaccine t...
Read more
(Sharecast News) - It remains to be seen whether the world needs new vaccines to fend off the new strains of novel coronavirus, a top researcher said.
Read more(Adds quotes, details)By Dominique VidalonPARIS, Feb 9 (Reuters) - The COVID-19 situation in France is currently stable and the government was right to have decided against imposing a new national lockdown, Health Minister Olivier Veran said on Tu...
Read more(Sharecast News) - The novel coronavirus vaccine developed by AstraZeneca and the University of Oxford is likely effective in preventing severe cases of Covid-19, or those requiring hospitalisation, analysts at Shore Capital said.
Read more(Updates with confirmation from Russia)By Asif ShahzadISLAMABAD, Feb 9 (Reuters) - Russia's Sputnik V has become the third COVID-19 vaccine to be approved by Pakistan for emergency use after China's Sinopharm and the one developed by AstraZeneca a...
Read more(Adds details)By Asif ShahzadISLAMABAD, Feb 9 (Reuters) - Russia's Sputnik-V has become the third COVID-19 vaccine to be approved by Pakistan for emergency use after China's Sinopharm and the ones developed by AstraZeneca and Oxford University, th...
Read more(Updates with more details, background)By Asif ShahzadISLAMABAD, Feb 9 (Reuters) - Russia's Sputnik-V has become the third COVID-19 vaccine to be approved by Pakistan for emergency use after China's Sinopharm and the one developed by AstraZeneca a...
Read more* Jury out on need for new vaccines - Oxford's Pollard* South Africa pauses AstraZeneca rollout after study* New vaccines are being developed to cope with new variants* World will be 'fine' as shots stop death and grave illness (Adds details, contex...
Read more(Adds details and quotes)LONDON, Feb 9 (Reuters) - It is not yet clear whether or not the world needs a new set of vaccines to fight different variants of the novel coronavirus but scientists are working on new ones so there is no reason for alarm...
Read more* Says no S. Africa variant reported, no concerns with shot* J&J interested in making its vaccine in India- govt official* Bharat Biotech may export local shot to Brazil, UAE this week* India orders 14.5 mln more doses of Astra, Bharat Biotech sho...
Read more* Exports to Brazil, UAE likely this week- Bharat Biotech* India using Bharat Biotech's COVAXIN in vaccination drive* India orders 14.5 mln more doses of COVAXIN, AstraZeneca shot (Adds details, quotes)By Anuron Kumar Mitra and Krishna N. DasNEW DE...
Read moreLONDON, Feb 9 (Reuters) - It is not yet clear whether or not the world needs a new set of vaccines to fight different variants of the novel coronavirus but scientists are working on new ones so there is no reason for alarm, the head of the Oxford ...
Read morePARIS, Feb 9 (Reuters) - Health Minister Olivier Veran said on Tuesday the COVID-19 situation was currently stable in France and that the government was right to have decided against imposing a new national lockdown.Veran also told France Info rad...
Read moreISLAMABAD, Feb 9 (Reuters) - Russia's Sputnik-V has become the third COVID-19 vaccine to be approved by Pakistan for emergency use after China's Sinopharm and the one developed by AstraZeneca and Oxford University, the country's health minister s...
Read more
Last checked at